Home
/
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
/
Financials
/
Quarterly
LIXTE BIOTECHNOLOGY HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2013
Sep 30, 2013
$0
Nov 7, 2013
Q2
2013
Jun 30, 2013
$0
Aug 5, 2013
Q1
2013
Mar 31, 2013
$0
May 9, 2013
Q3
2013
Sep 30, 2012
$0
Nov 7, 2013
Q2
2013
Jun 30, 2012
$0
Aug 5, 2013
Q1
2013
Mar 31, 2012
$0
May 9, 2013
Q3
2012
Sep 30, 2011
$0
Nov 13, 2012
Q2
2012
Jun 30, 2011
$0
Aug 10, 2012
Q1
2012
Mar 31, 2011
$0
May 10, 2012
Q3
2011
Sep 30, 2010
$0
Nov 10, 2011
Q2
2011
Jun 30, 2010
$0
Aug 12, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.98M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($775.7K)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($709.6K)
May 12, 2025
Q3
2025
Sep 30, 2024
($986.0K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.01M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($971.3K)
May 12, 2025
Q3
2024
Sep 30, 2023
($1.02M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.67M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($1.37M)
May 9, 2024
Q3
2023
Sep 30, 2022
($1.48M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($1.55M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($1.66M)
May 10, 2023
Q3
2022
Sep 30, 2021
($1.24M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($1.73M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($1.73M)
May 11, 2022
Q3
2021
Sep 30, 2020
($1.60M)
Nov 10, 2021
Q3
2020
Jun 30, 2020
($373.1K)
Nov 10, 2020
Q2
2021
Jun 30, 2020
($373.1K)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($383.2K)
May 12, 2021
Q3
2020
Mar 31, 2020
($383.2K)
Nov 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.80M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($774.8K)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($706.9K)
May 12, 2025
Q3
2025
Sep 30, 2024
($983.3K)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.01M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($966.9K)
May 12, 2025
Q3
2024
Sep 30, 2023
($1.02M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.67M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($1.37M)
May 9, 2024
Q3
2023
Sep 30, 2022
($1.48M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($1.55M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($1.65M)
May 10, 2023
Q3
2022
Sep 30, 2021
($1.24M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($1.73M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($1.73M)
May 11, 2022
Q3
2021
Sep 30, 2020
($1.60M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($373.4K)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($387.2K)
May 12, 2021
Q3
2020
Sep 30, 2019
($1.09M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($627.9K)
Aug 10, 2020